Cargando…
A single, continuous metric to define tiered serum neutralization potency against HIV
HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788501/ https://www.ncbi.nlm.nih.gov/pubmed/29350181 http://dx.doi.org/10.7554/eLife.31805 |
_version_ | 1783296090832896000 |
---|---|
author | Hraber, Peter Korber, Bette Wagh, Kshitij Montefiori, David Roederer, Mario |
author_facet | Hraber, Peter Korber, Bette Wagh, Kshitij Montefiori, David Roederer, Mario |
author_sort | Hraber, Peter |
collection | PubMed |
description | HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most circulating viruses are tier 2, vaccines that elicit neutralization responses against them are needed. While tier classification is widely used for viruses, a way to rate serum or antibody neutralization responses in comparable terms is needed. Logistic regression of neutralization outcomes summarizes serum or antibody potency on a continuous, tier-like scale. It also tests significance of the neutralization score, to indicate cases where serum response does not depend on virus tiers. The method can standardize results from different virus panels, and could lead to high-throughput assays, which evaluate a single serum dilution, rather than a dilution series, for more efficient use of limited resources to screen samples from vaccinees. |
format | Online Article Text |
id | pubmed-5788501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-57885012018-01-31 A single, continuous metric to define tiered serum neutralization potency against HIV Hraber, Peter Korber, Bette Wagh, Kshitij Montefiori, David Roederer, Mario eLife Epidemiology and Global Health HIV-1 Envelope (Env) variants are grouped into tiers by their neutralization-sensitivity phenotype. This helped to recognize that tier 1 neutralization responses can be elicited readily, but do not protect against new infections. Tier 3 viruses are the least sensitive to neutralization. Because most circulating viruses are tier 2, vaccines that elicit neutralization responses against them are needed. While tier classification is widely used for viruses, a way to rate serum or antibody neutralization responses in comparable terms is needed. Logistic regression of neutralization outcomes summarizes serum or antibody potency on a continuous, tier-like scale. It also tests significance of the neutralization score, to indicate cases where serum response does not depend on virus tiers. The method can standardize results from different virus panels, and could lead to high-throughput assays, which evaluate a single serum dilution, rather than a dilution series, for more efficient use of limited resources to screen samples from vaccinees. eLife Sciences Publications, Ltd 2018-01-19 /pmc/articles/PMC5788501/ /pubmed/29350181 http://dx.doi.org/10.7554/eLife.31805 Text en http://creativecommons.org/publicdomain/zero/1.0/ http://creativecommons.org/publicdomain/zero/1.0/This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (http://creativecommons.org/publicdomain/zero/1.0/) . |
spellingShingle | Epidemiology and Global Health Hraber, Peter Korber, Bette Wagh, Kshitij Montefiori, David Roederer, Mario A single, continuous metric to define tiered serum neutralization potency against HIV |
title | A single, continuous metric to define tiered serum neutralization potency against HIV |
title_full | A single, continuous metric to define tiered serum neutralization potency against HIV |
title_fullStr | A single, continuous metric to define tiered serum neutralization potency against HIV |
title_full_unstemmed | A single, continuous metric to define tiered serum neutralization potency against HIV |
title_short | A single, continuous metric to define tiered serum neutralization potency against HIV |
title_sort | single, continuous metric to define tiered serum neutralization potency against hiv |
topic | Epidemiology and Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788501/ https://www.ncbi.nlm.nih.gov/pubmed/29350181 http://dx.doi.org/10.7554/eLife.31805 |
work_keys_str_mv | AT hraberpeter asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT korberbette asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT waghkshitij asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT montefioridavid asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT roederermario asinglecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT hraberpeter singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT korberbette singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT waghkshitij singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT montefioridavid singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv AT roederermario singlecontinuousmetrictodefinetieredserumneutralizationpotencyagainsthiv |